European Stroke Prevention Study. ESPS Group

« Previous Article | Table of Contents | Next Article »

Stroke. 1990;21:1122-1130

This Article

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Citation Map

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Request Permissions

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Search for Related Content

PubMed

PubMed Citation

Pubmed/NCBI databases

Hazardous Substances DB
Compound via MeSH
Substance via MeSH
ACETYLSALICYLIC ACID

ARTICLES

European Stroke Prevention Study. ESPS Group

We compared the outcomes of 2,500 patients who suffered from previous cerebrovascular disorders (transient ischemic attacks, reversible ischemic neurologic deficits, or completed strokes) treated with acetylsalicylic acid plus dipyridamole or matched placebo and followed for 2 years. Treatment was associated with a 33.5% reduction (p less than 0.001) in the incidence of all end points (deaths from all causes or strokes) by intention-to-treat analysis and a 36.5% reduction (p less than 0.001) by explanatory analysis. End point reduction appeared to be similar in men and women. The effect of treatment was similar regardless of the patients' age, nature of the qualifying cerebrovascular event, site of the responsible lesion, and diastolic blood pressure. Our results demonstrate the efficacy of combined therapy, but the efficacy of acetylsalicylic acid or dipyridamole alone and the most effective acetylsalicylic acid dosage remain in question.

This article has been cited by other articles:

J. K. Liao
Secondary Prevention of Stroke and Transient Ischemic Attack: Is More Platelet Inhibition the Answer?
Circulation, March 27, 2007; 115(12): 1615 - 1621.
[Abstract] [Full Text] [PDF]

Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]

V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]

V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]

V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]

V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]

Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]

M. S. Dhamoon, R. R. Sciacca, T. Rundek, R. L. Sacco, and M.S.V. Elkind
Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study
Neurology, March 14, 2006; 66(5): 641 - 646.
[Abstract] [Full Text] [PDF]

E. Touze, O. Varenne, G. Chatellier, S. Peyrard, P. M. Rothwell, and J.-L. Mas
Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis
Stroke, December 1, 2005; 36(12): 2748 - 2755.
[Abstract] [Full Text] [PDF]

B. Bates, J. Y. Choi, P. W. Duncan, J. J. Glasberg, G. D. Graham, R. C. Katz, K. Lamberty, D. Reker, and R. Zorowitz
Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: Executive Summary
Stroke, September 1, 2005; 36(9): 2049 - 2056.
[Abstract] [Full Text] [PDF]

J. Leonardi-Bee, P. M.W. Bath, M.-G. Bousser, A. Davalos, H.-C. Diener, B. Guiraud-Chaumeil, J. Sivenius, F. Yatsu, M. E. Dewey, and on behalf of the Dipyridamole in Stroke Collaborat
Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events: A Meta-Analysis of Individual Patient Data From Randomized Controlled Trials
Stroke, January 1, 2005; 36(1): 162 - 168.
[Abstract] [Full Text] [PDF]

M. A. Creager, D. W. Jones, J. D. Easton, J. L. Halperin, A. T. Hirsch, A. H. Matsumoto, P. T. O'Gara, R. D. Safian, G. L. Schwartz, and J. A. Spittell
Atherosclerotic Vascular Disease Conference: Writing Group V: Medical Decision Making and Therapy
Circulation, June 1, 2004; 109(21): 2634 - 2642.
[Full Text] [PDF]

R. J. Adams, M. I. Chimowitz, J. S. Alpert, I. A. Awad, M. D. Cerqueria, P. Fayad, and K. A. Taubert
Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association
Circulation, September 9, 2003; 108(10): 1278 - 1290.
[Full Text] [PDF]

R. J. Adams, M. I. Chimowitz, J. S. Alpert, I. A. Awad, M. D. Cerqueria, P. Fayad, and K. A. Taubert
Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association
Stroke, September 1, 2003; 34(9): 2310 - 2322.
[Full Text] [PDF]

E. Flossmann and P. M. Rothwell
Prognosis of vertebrobasilar transient ischaemic attack and minor stroke
Brain, September 1, 2003; 126(9): 1940 - 1954.
[Abstract] [Full Text] [PDF]

E.L.L.M. De Schryver, A. Algra, and J. van Gijn
Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular Disease
Stroke, August 1, 2003; 34(8): 2072 - 2080.
[Abstract] [Full Text] [PDF]

J. Matias-Guiu, J. M. Ferro, J. Alvarez-Sabin, F. Torres, M. D. Jimenez, A. Lago, T. Melo, and D. C. Tong
Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction: The TACIP Study: A Randomized, Double-Blind, Multicenter Trial * Can Aspirin Ever Be Surpassed for Stroke Prevention?
Stroke, April 1, 2003; 34(4): 840 - 848.
[Abstract] [Full Text] [PDF]

P. C. Gates, M. Eliasziw, A. Algra, H. J.M. Barnett, and R. W. Gunton
Identifying Patients With Symptomatic Carotid Artery Disease at High and Low Risk of Severe Myocardial Infarction and Cardiac Death
Stroke, October 1, 2002; 33(10): 2413 - 2416.
[Abstract] [Full Text] [PDF]

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923.
[PDF]

V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266.
[Full Text] [PDF]

J. M. Holroyd-Leduc, M. K. Kapral, P. C. Austin, and J. V. Tu
Sex Differences and Similarities in the Management and Outcome of Stroke Patients
Stroke, August 1, 2000; 31(8): 1833 - 1837.
[Abstract] [Full Text] [PDF]

R. L. Sacco and M. S. Elkind
Update on Antiplatelet Therapy for Stroke Prevention
Arch Intern Med, June 12, 2000; 160(11): 1579 - 1582.
[Full Text] [PDF]

R. L. Hughes, G. W. Albers, R. G. Hart, H. L. Lutsep, D. W. Newell, and R. L. Sacco
Supplement to the AHA Guidelines for the Management of Transient Ischemic Attacks � Response to Dr Hughes:
Stroke, April 1, 2000; 31 (4): 983 - 991.
[Full Text]

G. W. Albers
Choice of endpoints in antiplatelet trials: Which outcomes are most relevant to stroke patients?
Neurology, March 14, 2000; 54(5): 1022 - 1028.
[Abstract] [Full Text] [PDF]

T. Hillen, R. Dundas, E. Lawrence, J. A. Stewart, A. G. Rudd, and C. D. A. Wolfe
Antithrombotic and Antihypertensive Management 3 Months After Ischemic Stroke : A Prospective Study in an Inner City Population
Stroke, February 1, 2000; 31(2): 469 - 475.
[Abstract] [Full Text] [PDF]

J. L. Wilterdink and J. D. Easton
Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol, September 1, 1999; 56(9): 1087 - 1092.
[Abstract] [Full Text] [PDF]

J. Sivenius, L. Cunha, H.-C. Diener, C. Forbes, M. Laakso, A. Lowenthal, P. Smets, and P. Riekkinen Sr.
Antiplatelet treatment does not reduce the severity of subsequent stroke
Neurology, September 1, 1999; 53(4): 825 - 825.
[Abstract] [Full Text] [PDF]

A. G Thrift, J. J McNeil, A. Forbes, and G. A Donnan
Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study
BMJ, March 20, 1999; 318(7186): 759 - 764.
[Abstract] [Full Text]

J. P. De La Cruz, A. Moreno, M. Muñoz, J. M.�G. Campos, and F. S. De La Cuesta
Effect of Aspirin Plus Dipyridamole on the Retinal Vascular Pattern in Experimental Diabetes Mellitus
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 454 - 459.
[Abstract] [Full Text]

C. Patrono and G. J. Roth
Aspirin in Ischemic Cerebrovascular Disease : How Strong Is the Case for a Different Dosing Regimen?
Stroke, April 1, 1996; 27(4): 756 - 760.
[Abstract] [Full Text]

H. J.M. Barnett, M. Eliasziw, and H. E. Meldrum
Drugs and Surgery in the Prevention of Ischemic Stroke
N. Engl. J. Med., January 26, 1995; 332(4): 238 - 248.
[Full Text] [PDF]

J. C Grotta
Prevention and management of stroke
Vascular Medicine, March 1, 1991; 2(1): 3 - 17.
[PDF]

				Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF]

				Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF]

				M. S. Dhamoon, R. R. Sciacca, T. Rundek, R. L. Sacco, and M.S.V. Elkind Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study Neurology, March 14, 2006; 66(5): 641 - 646. [Abstract] [Full Text] [PDF]

				E. Touze, O. Varenne, G. Chatellier, S. Peyrard, P. M. Rothwell, and J.-L. Mas Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis Stroke, December 1, 2005; 36(12): 2748 - 2755. [Abstract] [Full Text] [PDF]

				B. Bates, J. Y. Choi, P. W. Duncan, J. J. Glasberg, G. D. Graham, R. C. Katz, K. Lamberty, D. Reker, and R. Zorowitz Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: Executive Summary Stroke, September 1, 2005; 36(9): 2049 - 2056. [Abstract] [Full Text] [PDF]

				J. Leonardi-Bee, P. M.W. Bath, M.-G. Bousser, A. Davalos, H.-C. Diener, B. Guiraud-Chaumeil, J. Sivenius, F. Yatsu, M. E. Dewey, and on behalf of the Dipyridamole in Stroke Collaborat Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events: A Meta-Analysis of Individual Patient Data From Randomized Controlled Trials Stroke, January 1, 2005; 36(1): 162 - 168. [Abstract] [Full Text] [PDF]

				M. A. Creager, D. W. Jones, J. D. Easton, J. L. Halperin, A. T. Hirsch, A. H. Matsumoto, P. T. O'Gara, R. D. Safian, G. L. Schwartz, and J. A. Spittell Atherosclerotic Vascular Disease Conference: Writing Group V: Medical Decision Making and Therapy Circulation, June 1, 2004; 109(21): 2634 - 2642. [Full Text] [PDF]

				R. J. Adams, M. I. Chimowitz, J. S. Alpert, I. A. Awad, M. D. Cerqueria, P. Fayad, and K. A. Taubert Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association Circulation, September 9, 2003; 108(10): 1278 - 1290. [Full Text] [PDF]

				E. Flossmann and P. M. Rothwell Prognosis of vertebrobasilar transient ischaemic attack and minor stroke Brain, September 1, 2003; 126(9): 1940 - 1954. [Abstract] [Full Text] [PDF]

				E.L.L.M. De Schryver, A. Algra, and J. van Gijn Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular Disease Stroke, August 1, 2003; 34(8): 2072 - 2080. [Abstract] [Full Text] [PDF]

				J. Matias-Guiu, J. M. Ferro, J. Alvarez-Sabin, F. Torres, M. D. Jimenez, A. Lago, T. Melo, and D. C. Tong Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction: The TACIP Study: A Randomized, Double-Blind, Multicenter Trial * Can Aspirin Ever Be Surpassed for Stroke Prevention? Stroke, April 1, 2003; 34(4): 840 - 848. [Abstract] [Full Text] [PDF]

				P. C. Gates, M. Eliasziw, A. Algra, H. J.M. Barnett, and R. W. Gunton Identifying Patients With Symptomatic Carotid Artery Disease at High and Low Risk of Severe Myocardial Infarction and Cardiac Death Stroke, October 1, 2002; 33(10): 2413 - 2416. [Abstract] [Full Text] [PDF]

				Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF]

				V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF]

				J. M. Holroyd-Leduc, M. K. Kapral, P. C. Austin, and J. V. Tu Sex Differences and Similarities in the Management and Outcome of Stroke Patients Stroke, August 1, 2000; 31(8): 1833 - 1837. [Abstract] [Full Text] [PDF]

				R. L. Sacco and M. S. Elkind Update on Antiplatelet Therapy for Stroke Prevention Arch Intern Med, June 12, 2000; 160(11): 1579 - 1582. [Full Text] [PDF]

				R. L. Hughes, G. W. Albers, R. G. Hart, H. L. Lutsep, D. W. Newell, and R. L. Sacco Supplement to the AHA Guidelines for the Management of Transient Ischemic Attacks � Response to Dr Hughes: Stroke, April 1, 2000; 31 (4): 983 - 991. [Full Text]

				G. W. Albers Choice of endpoints in antiplatelet trials: Which outcomes are most relevant to stroke patients? Neurology, March 14, 2000; 54(5): 1022 - 1028. [Abstract] [Full Text] [PDF]

				T. Hillen, R. Dundas, E. Lawrence, J. A. Stewart, A. G. Rudd, and C. D. A. Wolfe Antithrombotic and Antihypertensive Management 3 Months After Ischemic Stroke : A Prospective Study in an Inner City Population Stroke, February 1, 2000; 31(2): 469 - 475. [Abstract] [Full Text] [PDF]

				J. L. Wilterdink and J. D. Easton Dipyridamole Plus Aspirin in Cerebrovascular Disease Arch Neurol, September 1, 1999; 56(9): 1087 - 1092. [Abstract] [Full Text] [PDF]

				J. Sivenius, L. Cunha, H.-C. Diener, C. Forbes, M. Laakso, A. Lowenthal, P. Smets, and P. Riekkinen Sr. Antiplatelet treatment does not reduce the severity of subsequent stroke Neurology, September 1, 1999; 53(4): 825 - 825. [Abstract] [Full Text] [PDF]

				A. G Thrift, J. J McNeil, A. Forbes, and G. A Donnan Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study BMJ, March 20, 1999; 318(7186): 759 - 764. [Abstract] [Full Text]

				J. P. De La Cruz, A. Moreno, M. Muñoz, J. M.�G. Campos, and F. S. De La Cuesta Effect of Aspirin Plus Dipyridamole on the Retinal Vascular Pattern in Experimental Diabetes Mellitus J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 454 - 459. [Abstract] [Full Text]

				C. Patrono and G. J. Roth Aspirin in Ischemic Cerebrovascular Disease : How Strong Is the Case for a Different Dosing Regimen? Stroke, April 1, 1996; 27(4): 756 - 760. [Abstract] [Full Text]

				H. J.M. Barnett, M. Eliasziw, and H. E. Meldrum Drugs and Surgery in the Prevention of Ischemic Stroke N. Engl. J. Med., January 26, 1995; 332(4): 238 - 248. [Full Text] [PDF]

				J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF]